Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

26 Apr 2024

17.17

0.12%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

BSE India

Mr.Ravi Shankar kabra, CFO of the company tendered his resignation vide letter dated April 25,2024 due to health reasons and other pre occupations, he will be relieved of his duties effective end of business hours of April 26,2024

pdf

Lasa Supergenerics Ltd.

15 Apr 2024

17.17

0.12%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under regulation 74 (5) SEBI (Depositories and Participants) Regulation''s, 2018 for the quarter and the year ended March 31, 2024 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Lasa Supergenerics Ltd.

15 Apr 2024

17.17

0.12%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliance Under Reg 7(3) SEBI LODR, Regulations 2015 For The …

BSE India

Pursuant to Regulation 7 (3) of SEBI LODR, Regulations 2015, We hereby confirm that all activities in relation to both physical and electronic share transfer facility during period 1st April 2023 to 31st March, 2024 (both days inclusive) are maintained by our Registrar and Share Transfer Agent - BigShare Services Private Limited having permanant SEBI Registration No. INR000001385

pdf

Lasa Supergenerics Ltd.

29 Mar 2024

17.17

0.12%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to Inform you that as per the company code of Conduct for Regulation Monitoring and Reporting of Trading by Insiders in terms of ( Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading window for dealing of Equity Share of the Company has been closed for designated employee and their immediate relatives w.e.f 1st April 2024 to till the 48 hours after the declaration of Audited Financial result (both days inclusive) for the quarter and the year ended March 31, 2024

pdf

Lasa Supergenerics Ltd.

11 Mar 2024

17.17

0.12%

Company Update

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Revised Outcome Disclosure Under Regulation 30 …

BSE India

Revised outcome of Board Meeting March 08, 2024 Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held on March 08, 2024 which was commenced at 2.00 p.m. and concluded at 3.00 p.m. inter- alia have considered and approved the following: 1. Appointment of Mr. Umesh Pawar (DIN: 10539778) as an Additional Director (Executive Director) of the Company and he shall be designated as Whole-time Director of the Company for a term of 5 (five) years with effect from March 08, 2024, subject to the approval of shareholders at General Meeting of the Company.. We are enclosing herewith the brief details of the aforesaid change as prescribed under SEBI Listing Regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, as Annexure I.

pdf

Lasa Supergenerics Ltd.

08 Mar 2024

17.17

0.12%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 p.m. and concluded at 3.00 p.m. inter- alia have considered and approved the following: 1. Appointment of Mr. Umesh Pawar as an Additional Director (Executive Director) of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.

pdf

Lasa Supergenerics Ltd.

13 Feb 2024

17.17

0.12%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting For The …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 4.00 p.m. and concluded at 6.15 p.m. inter- alia have considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the quarter ended on December 31, 2023. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2023.

pdf

Lasa Supergenerics Ltd.

05 Feb 2024

17.17

0.12%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for For Unaudited Financial Results Along With …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 13, 2024 1. To consider, approve and take on records unaudited financial results of the Company along with the Limited Review Report from the Statutory Auditor for the quarter ended on December 31, 2023. 2. To discuss any other matter with the permission of the Chairperson.

pdf

Lasa Supergenerics Ltd.

16 Jan 2024

17.17

0.12%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended December 31, 2023 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company

pdf

Lasa Supergenerics Ltd.

30 Dec 2023

17.17

0.12%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

As per Company''s Code of Conduct for regulating monitoring and reporting of trading by insiders terms of (prohibition f insiders trading)Regulations 2015, as amended the trading window for dealing in equity shares of the company has been closed for the designated employees and their relatives w.e.f from January 1, 2024to till 48 hours after the declaration of unaudited financial results (both inclusive days) for quarter ended December 31, 2023

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%